Concepedia
Statistics
Publications
11
Citations
460
H-Index
Active since
1997
Affiliations
Pfizer (United States)(Current)
Johns Hopkins Hospital
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases
Christopher S. Knauer is an author at Pfizer (United States) specializing in pharmacology, medicine, and receptor pharmacology.
Publications per year
1997–2016
Discovery of sarolaner: A novel, orally administered, broad-spectrum, isoxazoline ectoparasiticide for dogs
Tom L. McTier, Nathan Chubb, Michael P. Curtis et al. · Veterinary Parasitology · 2016 · 130 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +14
Discovery of veterinary antiparasitic agents in the 21st Century: A view from industry
Debra J. Woods, Christopher S. Knauer · International Journal for Parasitology · 2010 · 56 citations
Veterinary Medicine, Veterinary Parasitology, Veterinary Pharmacology +11
Distinct Loci Mediate the Direct and Indirect Actions of the Anesthetic Etomidate at GABA<sub>A</sub> Receptors
Eric J. Moody, Christopher S. Knauer, Ricardo Granja et al. · Journal of Neurochemistry · 1997 · 46 citations · Full text
Medicine, Neurobiology, Pharmacology +17
Heteroatom-linked indanylpyrazines are corticotropin releasing factor type-1 receptor antagonists
Jeffrey W. Corbett, Mark R. Rauckhorst, Fang Qian et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 41 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +6
2,3,4,5-Tetrahydro- and 2,3,4,5,11,11a-hexahydro-1H-[1,4]diazepino[1,7-a]indoles: new templates for 5-HT2C agonists
Michael D. Ennis, Robert L. Hoffman, Nabil B. Ghazal et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 34 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +13
1–5 of 11